The AI revolution in drug discovery: a status update for 2023

Written by Philippe Moingeon (Servier)

In this opinion piece, Philippe Moingeon (Servier, France) discusses the success of AI and machine learning (ML) in accelerating and optimizing drug discovery and design. Philippe discusses how AI algorithms can help tailor treatments personalized to patients, and his opinion regarding the future directions of AI in drug discovery.  A successful leveraging of AI and ML to accelerate drug discovery AI and ML have been successfully utilized to support drug discovery, with evidence that they can significantly accelerate the design and optimization of novel drugs, making it more efficient, accurate and cost-effective [1,2]. For example, a novel antibiotic termed Halicin,...

To view this content, please register now for access

It's completely free